Exchange
SZSE
Every company in the roster listed on SZSE.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
8 of 8 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Haisco Pharmaceutical Group002653 · SZSE | 9 assets: 5 Ph 3, 1 Ph 2, 2 Ph 1, 1 other | Anrikefon (HSK21542)Phase 3 · Chronic Kidney DiseaseReliable signal | 31 Oct 2026HSK44459 · Phase 2 |
 Shenzhen Salubris Pharmaceuticals002294 · SZSE | 7 assets: 3 Ph 3, 4 Ph 2 | EnarodustatPhase 3 · Chronic Kidney DiseaseReliable signal | 31 Oct 2026JK07 · Phase 2 |
 Hangzhou Zhongmei Huadong Pharmaceutical000963 · SZSE | 5 assets: 3 Ph 3, 1 Ph 1, 1 other | HDG1901Phase 3 · Type 2 DiabetesPartial signal | 10 Oct 2026HDM1002 · Phase 3 |
 Chengdu Kanghong Pharmaceutical002773 · SZSE | 2 assets: 2 Ph 3 | KH607Phase 3 · Major Depressive DisorderPartial signal | Dec 2027KH607 · Phase 3 |
 Jiangsu Nhwa Pharmaceutical Co., Ltd.002262 · SZSE | 2 assets: 1 Ph 2, 1 Ph 1 | NH102Phase 2 · Major Depressive DisorderPartial signal | None on record |
| 1 asset: 1 Ph 2 | MetacavirPhase 2 · Chronic Hepatitis B | None on record | |
 China Resources Sanjiu Medical & Pharmaceutical000999 · SZSE | 1 asset: 1 Ph 3 | Shenfu injectionPhase 2/3 · Heart Failure | None on record |
 Sichuan Kelun Pharmaceutical Co., Ltd.002422 · SZSE | 1 asset: 1 Ph 1 | Brexpiprazole long-acting injection (Kelun)Phase 1 · Schizophrenia | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).